arrow
L

Luis Jara-Palomares

Virgen del Rocio University Hospital
H指数:35
被引数:5,274

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Coated or chewable aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: rationale and design of the COATED-AIR randomized trial

包衣或咀嚼型阿司匹林及一种混合空气污染缓解策略在动脉粥样硬化患者中的应用:COATED-AIR随机试验的原理与设计

2026-09-230
OAAI
Development and external validation of an international score to predict cancer 1 year after venous thromboembolism

静脉血栓栓塞症后1年癌症发展的国际评分的开发与外部验证

2026-05-250
PRE
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial

癌症相关静脉血栓栓塞症延长抗凝治疗期间临床相关出血的预测因素(API-CAT):一项随机、非劣效性试验的事后分析

2025-12-060
PRE
The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis

奥塔瓦评分对接受那曲肝素治疗的癌症患者复发性静脉血栓栓塞症预测:一项基于个体患者数据的meta分析

2025-12-020
OAAI
Validation of the RISA-PE Risk Classification in Medically Managed Patients with Acute Pulmonary Embolism: A Multicenter Study

RISA-PE风险分类在经药物治疗的急性肺栓塞患者中的验证:一项多中心研究

2025-10-040
PRE
Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort study

癌症患者抗凝治疗期间复发性静脉血栓栓塞症的管理:一项前瞻性队列研究

2025-09-050
OAAI
Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study

靶向定量蛋白质组学在不明原因静脉血栓栓塞症患者中筛查隐匿性癌症的应用:前瞻性PLATO-VTE研究的结果

2025-08-190
OAAI
Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trial

血栓减少症患者及癌症相关血栓患者的抗凝策略(START):START试点随机对照试验的设计与原理

2025-05-010
OA
Occult cancer in patients with unprovoked venous thromboembolism: Rationale, design, and methods of the VaLRIETEs study and the SOME-RIETE trial
2025-02-010
PRE
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

新型冠状病毒肺炎疫苗后30天内静脉血栓栓塞患者停止抗凝治疗后的复发率

2024-09-040
PRE
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study
2024-09-011
OAAI
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19associated venous thromboembolism: a prospective multicentre cohort study

COVID-19associated静脉血栓栓塞症患者停止抗凝治疗后的复发风险: 一项前瞻性多中心队列研究

2024-07-011
OAAI